Product Information
The WALLSTENT Endoscopic Biliary Stent System offers an 8Fr low-profile design for passage through 3.2mm working channel and up to a 30Fr lumen diameter.
The WALLSTENT Endoprosthesis may be reconstrained and repositioned during deployment up to the limit marker band has been reached. The limit marker band will be reached when approximately 87% of the stent has been deployed. Reconstrainability may be limited by scope position or anatomy, among other factors.
Halo™ technology is designed to promote precise positioning through improved fluoroscopic visibility.
Device Illustration
Additional Information
MR Safe: The WALLSTENT Endoprosthesis will not present an additional hazard or risk to a patient undergoing an MRI procedure using an MR system operating with a static magnetic field of 1.5 Tesla or less.
MR Compatible: Use of the WALLSTENT Endoprosthesis in an MR environment may not adversely impact the image quality.
- The WALLSTENT Endoprosthesis is designed for RX compatibility to increase control in the hands of the physician.
- The UNISTEP® Plus Delivery System is engineered to lock a 260cm guidewire in place to help secure access throughout stent positioning and deployment.
- The single-operator exchange system is designed to provide enhanced efficiency by eliminating the need to manage a 450cm guidewire during an ERCP. This improves guidewire access placement to avoid difficult recannulation.
- Proprietary Permalume® Covering, a durable silastic polymer, helps resist tumor ingrowth
- The fully braided flexible delivery catheter is designed to resist kinking in tortuous anatomy.
- Four radiopaque markers on the sheath and catheter enhance deployment control.
